Oncology is the leading therapy area for innovation – in terms of the level of clinical trial activity, number of companies investing in therapeutics, size of the pipeline of therapies in clinical development, novel active substances being launched, and the level of expenditure on these drugs. In 2021, during a global pandemic, cancer care continued to be delivered although a backlog in treatment and screenings raised worrying questions.
